Clinical trial

Add-on Therapy With Edupression.Com® on Therapy Resistant Depressive Patients Treated With Nasal Esketamine Spray

NCT04843462

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention edupression.com® Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Esketamine nasal spray Normalized identity: esketamine Nasal SprayView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Add-on Therapy With Edupression.Com® on Therapy Resistant Depressive Patients Treated With Nasal Esketamine Spray

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-04-29

PhaseNA

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Therapy Resistant Depressionunresolved

Interventions

edupression.com®DEVICE

Esketamine nasal sprayDRUG · verified · RxNorm: esketamine Nasal Spray

Sponsors & collaborators

Lukas Pezawaslead sponsor

Mapped research locations

ViennaAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04843462 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.